Skip to main content
. 2020 Jan 29;7(2):626–638. doi: 10.1002/ehf2.12620

Table 1.

Characteristics of wild‐type or myeloid differentiation protein 1 knock‐out mice 4 Weeks after saline/aldosterone infusion

Groups WT‐Saline (n = 8) KO‐Saline (n = 8) WT‐Aldo (n = 8) KO‐Aldo (n = 8)
BW (g) 21.56 ± 0.35 22.28 ± 0.31 22.81 ± 0.34 23.59 ± 0.44*
HW/BW (mg/g) 4.56 ± 0.06 4.48 ± 0.07 5.82 ± 0.09* 6.82 ± 0.16*,**
LW/BW (mg/g) 4.98 ± 0.06 5.08 ± 0.1 6.96 ± 0.17* 7.77 ± 0.21*,**
LW/TL (mg/g) 5.85 ± 0.07 6.09 ± 0.1 8.5 ± 0.12* 9.94 ± 0.15*,**
LVEDd (mm) 3.9 ± 0.08 3.83 ± 0.09 3.85 ± 0.1 3.96 ± 0.07
LVESd (mm) 2.18 ± 0.06 2.11 ± 0.07 2.15 ± 0.07 2.35 ± 0.13
LVEF (%) 81.63 ± 0.8 82.12 ± 0.95 80.13 ± 1.91 77.13 ± 2.95
LVFS (%) 44.38 ± 0.01 44.63 ± 0.01 43.88 ± 0.02 40.63 ± 0.03
LAD (mm) 1.55 ± 0.04 1.59 ± 0.04 1.56 ± 0.1 1.59 ± 0.07
Serum aldosterone levels (pg/mL) 235.3 ± 19.09 238.79 ± 15.13 438.47 ± 12.85* 458.48 ± 10.8*

Aldo, Aldosterone; BW, body weight; HW, heart weight; KO, knock‐out; LAD, left atrial diameter; LVEDd, left ventricle end‐diastolic dimension; LVEF, left ventricular ejection fraction; LVFS, left ventricular fractional shortening; LVESd, left ventricular end‐systolic diameter; LW, lung weight; TL, tibial length.

Data are expressed as Mean ± standard error of the mean.

*

P < 0.05 vs. WT‐Sal group.

**

P < 0.05 vs. WT‐Aldo group.